News Daily News Similarly Low Risk of CV Events With Bivalent and Monovalent mRNA Boosters A retrospective analysis of nationwide French data does not support a regulatory alert issued in the US earlier this year. Shelley Wood March 29, 2023
Presentation ACC 2023 Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III) Presenter: Annapoorna S. Kini March 06, 2023
Presentation ACC 2023 Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease Presenter: Roberto Diletti March 05, 2023
Presentation CTO 2023 How to Use Non-Invasive Imaging to Guide Complex PCI? Presenter: Paul Knaapen February 24, 2023
Presentation CTO 2023 Finding the Sweet-Spot for Circulatory Support: What Modality and When? Presenter: Khaldoon Alaswad February 24, 2023
Presentation CTO 2023 Post CABG Revascularization – Pragmatic Graft Intervention or Native Vessel Reconstruction? Presenter: Kevin J. Croce February 24, 2023
News Daily News Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI By Michael O'Riordan March 31, 2023
News Daily News Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs By Shelley Wood March 31, 2023
News Daily News Similarly Low Risk of CV Events With Bivalent and Monovalent mRNA Boosters By Shelley Wood March 29, 2023
News Daily News Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term By Caitlin E. Cox March 28, 2023
News Daily News Second Recall in Less Than 2 Months for Cardiosave IABPs By L.A. McKeown March 17, 2023